Literature DB >> 30470620

Systemic infection with Candida albicans in breast tumor bearing mice: Cytokines dysregulation and induction of regulatory T cells.

N Ahmadi1, A Ahmadi2, E Kheirali3, M Hossein Yadegari4, M Bayat5, A Shajiei6, A Ali Amini7, S Ashrafi8, M Abolhassani3, S Faezi9, S Amir Yazdanparast10, M Mahdavi11.   

Abstract

OBJECTIVE: The effect of candidemia on immunologic parameters in breast tumor bearing patients is not well studied. Here, we hypothesised that candidemia in the tumor background may change the outcome of immunologic parameters and tumor condition.
METHOD: Mice were divided into four groups, including normal, tumor, Candida infected (only Candidiasis) and tumor/Candidiasis groups. Tumor changes were recorded daily after tumor transplantation and induction of candidemia. Splenocytes of mice were harvested, cultured, and stimulated with PHA; afterwards, IL-4, IL-10, IFN-γ, TNF-α and TGF-β cytokines were assessed using ELISA kits. We also evaluated the population of CD4+CD25+Foxp3+ regulatory T cells in the tumor infiltrated and splenocytes.
RESULTS: The results showed that infection with C. albicans decreased the IFN-γ/IL-4 ratio in tumor/candidiasis and candidiasis groups versus their non-infected controls. IL-10, TGF-β and TNF-α levels increased in the candidiasis group. In addition, Candidemia led to an increase in the Treg population in tumor microenvironment and splenocytes of experimental groups compared with non-infected controls. Finally, candidemia increased tumor growth of tumor/Candidiasis group compared with the tumor group.
CONCLUSION: It seems that systemic infection with C. albicans could not only induce regulatory T cells but also result in dysregulation of cytokine network and thereby facilitate tumor growth.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Candida albicans; Cytokines; Regulatory T cells; Tumor growth

Mesh:

Substances:

Year:  2018        PMID: 30470620     DOI: 10.1016/j.mycmed.2018.10.006

Source DB:  PubMed          Journal:  J Mycol Med        ISSN: 1156-5233            Impact factor:   2.391


  7 in total

1.  Candida albicans culture from a rectal swab can be associated with newly diagnosed colorectal cancer.

Authors:  Lubomír Starý; Kristýna Mezerová; Kamil Vysloužil; Pavel Zbořil; Pavel Skalický; Martin Stašek; Vladislav Raclavský
Journal:  Folia Microbiol (Praha)       Date:  2020-06-29       Impact factor: 2.099

Review 2.  Insight Into Regulatory T Cells in Sepsis-Associated Encephalopathy.

Authors:  Yu-Lei Gao; Yan-Cun Liu; Xiang Zhang; Song-Tao Shou; Yan-Fen Chai
Journal:  Front Neurol       Date:  2022-03-16       Impact factor: 4.003

3.  Intestinal Candida albicans Promotes Hepatocarcinogenesis by Up-Regulating NLRP6.

Authors:  Zherui Liu; Yinyin Li; Chen Li; Guanglin Lei; Lin Zhou; Xiangling Chen; Xiaodong Jia; Yinying Lu
Journal:  Front Microbiol       Date:  2022-03-08       Impact factor: 5.640

Review 4.  Regulatory T Cells: Angels or Demons in the Pathophysiology of Sepsis?

Authors:  Yu-Lei Gao; Ying Yao; Xiang Zhang; Fang Chen; Xiang-Long Meng; Xin-Sen Chen; Chao-Lan Wang; Yan-Cun Liu; Xin Tian; Song-Tao Shou; Yan-Fen Chai
Journal:  Front Immunol       Date:  2022-02-25       Impact factor: 7.561

Review 5.  Mycobiota and C-Type Lectin Receptors in Cancers: Know thy Neighbors.

Authors:  Lilong Zhang; Dongqi Chai; Chen Chen; Chunlei Li; Zhendong Qiu; Tianrui Kuang; Mungur Parveena; Keshuai Dong; Jia Yu; Wenhong Deng; Weixing Wang
Journal:  Front Microbiol       Date:  2022-07-13       Impact factor: 6.064

Review 6.  The research progress in the interaction between Candida albicans and cancers.

Authors:  Dalang Yu; Zhiping Liu
Journal:  Front Microbiol       Date:  2022-09-28       Impact factor: 6.064

7.  The Overlooked Immune State in Candidemia: A Risk Factor for Mortality.

Authors:  Christian Ortega-Loubon; Beatriz Cano-Hernández; Rodrigo Poves-Alvarez; María Fe Muñoz-Moreno; Patricia Román-García; Sara Balbás-Alvarez; Olga de la Varga-Martínez; Esther Gómez-Sánchez; Estefanía Gómez-Pesquera; Mario Lorenzo-López; Eduardo Tamayo; María Heredia-Rodríguez
Journal:  J Clin Med       Date:  2019-09-20       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.